COLFAX CORP (CFX)

Common Stock

39.06  -1.53 (-3.77%)

After market: 39.06 0 (0%)

Fundamental Rating

3

Taking everything into account, CFX scores 3 out of 10 in our fundamental rating. CFX was compared to 132 industry peers in the Machinery industry. Both the profitability and financial health of CFX have multiple concerns. While showing a medium growth rate, CFX is valued expensive at the moment.



2

1. Profitability

1.1 Basic Checks

CFX had positive earnings in the past year.
CFX had positive earnings in 4 of the past 5 years.
CFX had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

Industry RankSector Rank
ROA 0.84%
ROE 1.55%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 8.76%
PM (TTM) 1.86%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

2

2. Health

2.1 Basic Checks

CFX has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, CFX has an improved debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 1.76, we must say that CFX is in the distress zone and has some risk of bankruptcy.
A Debt/Equity ratio of 0.45 indicates that CFX is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Altman-Z 1.76
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

CFX has a Current Ratio of 2.25. This indicates that CFX is financially healthy and has no problem in meeting its short term obligations.
A Quick Ratio of 1.49 indicates that CFX should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 2.25
Quick Ratio 1.49

5

3. Growth

3.1 Past

CFX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 53.24%, which is quite impressive.
CFX shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.43% yearly.
The Revenue has grown by 25.51% in the past year. This is a very strong growth!
CFX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.88% yearly.
EPS 1Y (TTM)53.24%
EPS 3Y-2.81%
EPS 5Y6.43%
EPS growth Q2Q15.69%
Revenue 1Y (TTM)25.51%
Revenue growth 3Y20.68%
Revenue growth 5Y3.88%
Revenue growth Q2Q23.57%

3.2 Future

Based on estimates for the next years, CFX will show a decrease in Earnings Per Share. The EPS will decrease by -6.00% on average per year.
The Revenue is expected to grow by 4.73% on average over the next years.
EPS Next Y241.51%
EPS Next 2Y13.59%
EPS Next 3Y11.71%
EPS Next 5Y-6%
Revenue Next Year7.2%
Revenue Next 2Y6.23%
Revenue Next 3Y5.31%
Revenue Next 5Y4.73%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 18.34, the valuation of CFX can be described as rather expensive.
The average S&P500 Price/Earnings ratio is at 28.02. CFX is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 5.37, the valuation of CFX can be described as very cheap.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.58, CFX is valued rather cheaply.
Industry RankSector Rank
PE 18.34
Fwd PE 5.37

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.44

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.08
PEG (5Y)2.85
EPS Next 2Y13.59%
EPS Next 3Y11.71%

0

5. Dividend

5.1 Amount

CFX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

COLFAX CORP

NYSE:CFX (4/4/2022, 7:16:47 PM)

After market: 39.06 0 (0%)

39.06

-1.53 (-3.77%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap6.10B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 18.34
Fwd PE 5.37
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.08
PEG (5Y)2.85
Profitability
Industry RankSector Rank
ROA 0.84%
ROE 1.55%
ROCE
ROIC
ROICexc
ROICexgc
OM 8.76%
PM (TTM) 1.86%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.25
Quick Ratio 1.49
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)53.24%
EPS 3Y-2.81%
EPS 5Y
EPS growth Q2Q
EPS Next Y241.51%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)25.51%
Revenue growth 3Y20.68%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y